pyrrolidin-3-yl-methanesulfonic acid has been researched along with Hemangiosarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esmail, A; Marafi, F; Usmani, S | 1 |
1 other study(ies) available for pyrrolidin-3-yl-methanesulfonic acid and Hemangiosarcoma
| Article | Year |
|---|---|
Prostate-Specific Membrane Antigen Expression in Metastatic Angiosarcoma Detected on 18F-PMSA PET/CT: A New Potential Prognostic Marker.
Topics: Gallium Radioisotopes; Hemangiosarcoma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Prostate; Prostatic Neoplasms; Pyrrolidines | 2022 |